Immunological principles regulating immunomodulation with biomaterials

Acta Biomaterialia

Volumn 10, Issue 4, 2014, Pages 1720-1727

  Khan, Tarik A ^a   Reddy, Sai T ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Adjuvants; Immunoengineering; Immunology; Vaccine delivery

Indexed keywords

BIOMATERIALS; BIOTECHNOLOGY;

ADAPTIVE IMMUNITY; ADJUVANT; CELLULARS; DESIGN MATERIALS; IMMUNO MODULATIONS; IMMUNOENGINEERING; INNATE IMMUNITY; MICROENVIRONMENTS; MOLECULAR PATTERNS; VACCINE DELIVERY;

IMMUNOLOGY;

BIOMATERIAL; FLAGELLIN; IMIDAZOQUINOLINE DERIVATIVE; LIPOPOLYSACCHARIDE; LIPOPROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RESIQUIMOD; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL ASSAY; CELL SURFACE; CELLULAR IMMUNITY; CPG ISLAND; ENDOSOME; EXPERIMENTAL MODEL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

HARNESS;

ADJUVANTS; IMMUNOENGINEERING; IMMUNOLOGY; VACCINE DELIVERY;

ADAPTIVE IMMUNITY; ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; IMMUNITY; IMMUNOMODULATION; MONITORING, IMMUNOLOGIC;

EID: 84896401312     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2013.12.011     Document Type: Review

References (108)

1. B. Guy The perfect mix: Recent progress in adjuvant research Nat Rev Microbiol 5 2007 505 517
2. M.F. Bachmann, and G.T. Jennings Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns Nat Rev Immunol 10 2010 787 796
3. J.A. Hubbell, S.N. Thomas, and M.A. Swartz Materials engineering for immunomodulation Nature 462 2009 449 460
4. R.M. Steinman Dendritic cells in vivo: A key target for a new vaccine science Immunity 29 2008 319 324
5. C.A. Janeway, and R. Medzhitov Innate immune recognition Annu Rev Immunol 20 2002 197 216
6. R. Medzhitov, P. Preston-Hurlburt, and C.A. Janeway A human homologue of the Drosophila Toll protein signals activation of adaptive immunity Nature 388 1997 394 397
7. B. Lemaitre, E. Nicolas, L. Michaut, J.-M. Reichhart, and J.A. Hoffmann The dorsoventral regulatory gene cassette spätzle/toll/cactus controls the potent antifungal response in drosophila adults Cell 86 1996 973 983
8. K. Takeda, and S. Akira TLR signaling pathways Semin Immunol 16 2004 3 9
9. K. Yang, A. Puel, S. Zhang, C. Eidenschenk, C.-L. Ku, and A. Casrouge et al. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses Immunity 23 2005 465 478
10. M.C. Rissoan, V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, and R. de Waal Malefyt et al. Reciprocal control of T helper cell and dendritic cell differentiation, Science 283 1999 1183 1186
11. J.M. Blander, and R. Medzhitov Toll-dependent selection of microbial antigens for presentation by dendritic cells Nature 440 2006 808 812
12. C.A. Thaiss, V. Semmling, L. Franken, H. Wagner, and C. Kurts Chemokines: A new dendritic cell signal for T cell activation Front Immunol 2 2011 1 9
13. D. Dowling, C.M. Hamilton, and S.M. O'Neill A comparative analysis of cytokine responses, cell surface marker expression and MAPKs in DCs matured with LPS compared with a panel of TLR ligands Cytokine 41 2008 254 262
14. M.L. Kapsenberg Dendritic-cell control of pathogen-driven T-cell polarization Nat Rev Immunol 3 2003 984 993
15. O. Schulz, A.D. Edwards, M. Schito, J. Aliberti, S. Manickasingham, and A. Sher et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal Immunity 13 2000 453 462
16. K. Farhat, S. Riekenberg, H. Heine, J. Debarry, R. Lang, and J. Mages et al. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling J Leukoc Biol 83 2008 692 701
17. J.Y. Kang, X. Nan, M.S. Jin, S.-J. Youn, Y.H. Ryu, and S. Mah et al. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer Immunity 31 2009 873 884
18. M.S. Jin, S.E. Kim, J.Y. Heo, M.E. Lee, H.M. Kim, and S.-G. Paik et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide Cell 130 2007 1071 1082
19. M. Matsumoto, and T. Seya TLR3: Interferon induction by double-stranded RNA including poly (I:C) Adv Drug Delivery Rev 60 2008 805 812
20. C. Wischke, J. Zimmermann, B. Wessinger, A. Schendler, H.-H. Borchert, and J.H. Peters et al. Poly(I:C) coated PLGA microparticles induce dendritic cell maturation Int J Pharm 365 2009 61 68
21. V. Mata-Haro, C. Cekic, M. Martin, P.M. Chilton, C.R. Casella, and T.C. Mitchell The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4 Science 316 2007 1628 1632
22. J.J. Moon, H. Suh, A. Bershteyn, M.T. Stephan, H. Liu, and B. Huang et al. Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses Nat Mater 10 2011 243 251
23. S.-I. Yoon, O. Kurnasov, V. Natarajan, M. Hong, A.V. Gudkov, and A.L. Osterman et al. Structural basis of TLR5-flagellin recognition and signaling Science 335 2012 859 864
24. M. Jurk, F. Heil, J. Vollmer, C. Schetter, A.M. Krieg, and H. Wagner et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 Nat Immunol 3 2002 499
25. T. Haas, J. Metzger, F. Schmitz, A. Heit, T. Müller, and E. Latz et al. The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation Immunity 28 2008 315 323
26. V.H. Shargh, M.R. Jaafari, A. Khamesipour, I. Jaafari, S.A. Jalali, and A. Abbasi Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis Vaccine 2012
27. S. Ingale, M.A. Wolfert, J. Gaekwad, T. Buskas, and G.-J. Boons Robust immune responses elicited by a fully synthetic three-component vaccine Nat Chem Biol 3 2007 663 667
28. K.L. Rock, D.J. Farfán-Arribas, and L. Shen Proteases in MHC class I presentation and cross-presentation J Immunol 184 2010 9 15
29. H.G. Rammensee Chemistry of peptides associated with MHC class I and class II molecules Curr Opin Immunol 7 1995 85 96
30. R.N. Germain MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation Cell 76 1994 287 299
31. P.-M. Kloetzel The proteasome and MHC class I antigen processing Biochim Biophys Acta 1695 2004 225 233
32. G.E. Meister, C.G. Roberts, J.A. Berzofsky, and A.S. De Groot Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences Vaccine 13 1995 581 591
33. O. Rötzschke, K. Falk, S. Stevanović, G. Jung, P. Walden, and H.G. Rammensee Exact prediction of a natural T cell epitope Eur J Immunol 21 1991 2891 2894
34. J. Neefjes, M.L.M. Jongsma, P. Paul, and O. Bakke Towards a systems understanding of MHC class I and MHC class II antigen presentation Nat Rev Immunol 11 2011 823 836
35. H. Shen, A.L. Ackerman, V. Cody, A. Giodini, E.R. Hinson, and P. Cresswell et al. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles Immunology 117 2006 78 88
36. M. Corr, D.J. Lee, D.A. Carson, and H. Tighe Gene vaccination with naked plasmid DNA: Mechanism of CTL priming J Exp Med 184 1996 1555 1560
37. T.M. Allen, T.U. Vogel, D.H. Fuller, B.R. Mothé, S. Steffen, and J.E. Boyson et al. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen J Immunol 164 2000 4968 4978
38. N.F. Rose, P.A. Marx, A. Luckay, D.F. Nixon, W.J. Moretto, and S.M. Donahoe et al. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Cell 106 2001 539 549
39. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs Nature 344 1990 873 875
40. R. Wang, D.L. Doolan, T.P. Le, R.C. Hedstrom, K.M. Coonan, and Y. Charoenvit et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine Science 282 1998 476 480
41. K. Huygen, O. Denis, D.L. Montgomery, A.M. Yawman, R.R. Deck, and C.M. DeWitt et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nat Med 2 1996 893 898
42. J.J. Moon, B. Huang, and D.J. Irvine Engineering Nano- and Microparticles to Tune Immunity Adv Mater 2012
43. C. Nembrini, A. Stano, K.Y. Dane, M. Ballester, A.J. van der Vlies, and B.J. Marsland et al. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination Proc Natl Acad Sci USA 108 2011 E989 97
44. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, and C.P. O'Neil et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat Biotechnol 25 2007 1159 1164
45. C. Münz Antigen processing via autophagy-not only for MHC class II presentation anymore? Curr Opin Immunol 22 2010 89 93
46. S.T. Reddy, A. Rehor, H.G. Schmoekel, J.A. Hubbell, and M.A. Swartz In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles J Control Release 112 2006 26 34
47. A. Rieux, E.G.E. Ragnarsson, E. Gullberg, V. Préat, Y.-J. Schneider, and P. Artursson Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium Eur J Pharm Sci 25 2005 455 465
48. A.T. Florence The oral absorption of micro- and nanoparticulates: Neither exceptional nor unusual Pharm Res 14 1997 259 266
49. Y. Tabata, Y. Inoue, and Y. Ikada Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres Vaccine 14 1996 1677 1685
50. M.G. Panthani, T.A. Khan, D.K. Reid, D.J. Hellebusch, M.R. Rasch, and J.A. Maynard et al. In Vivo whole animal fluorescence imaging of a microparticle-based oral vaccine containing (CuInSexS2-x)/ZnS core/shell quantum dots Nano Lett 13 2013 4294 4298
51. A.B. Watts, J.T. McConville, and R.O. Williams Current therapies and technological advances in aqueous aerosol drug delivery Drug Dev Ind Pharm 34 2008 913 922
52. P. Wanakule, G.W. Liu, A.T. Fleury, and K. Roy Nano-inside-micro: Disease-responsive microgels with encapsulated nanoparticles for intracellular drug delivery to the deep lung J Control Release 162 2012 429 437
53. C.M. Jewell, S.C.B. López, and D.J. Irvine In situ engineering of the lymph node microenvironment via intranodal injection of adjuvant-releasing polymer particles Proc Natl Acad Sci USA 108 2011 15745 15750
54. K.M. Murphy, P. Travers, M. Walport, and C. Janeway Janeway's Immunobiology 2011 Garland Pub
55. J. Maynard, K. Petersson, D.H. Wilson, E.J. Adams, S.E. Blondelle, and M.J. Boulanger et al. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: Insights into MHC bias and antigen specificity Immunity 22 2005 81 92
56. G.P. Morris, and P.M. Allen How the TCR balances sensitivity and specificity for the recognition of self and pathogens Nat Immunol 13 2012 121 128
57. A. Singh, H. Nie, B. Ghosn, H. Qin, L.W. Kwak, and K. Roy Efficient modulation of T-cell response by dual-mode, single-carrier delivery of cytokine-targeted siRNA and DNA vaccine to antigen-presenting cells Mol Ther 16 2008 2011 2021
58. M.T. Stephan, J.J. Moon, S.H. Um, A. Bershteyn, and D.J. Irvine Therapeutic cell engineering with surface-conjugated synthetic nanoparticles Nat Med 2010 1 31
59. J. Zhu, H. Yamane, and W.E. Paul Differentiation of effector CD4 T cell populations Annu Rev Immunol 28 2010 445
60. J.A. Bluestone, C.R. Mackay, J.J. O'Shea, and B. Stockinger The functional plasticity of T cell subsets Nat Rev Immunol 9 2009 811 816
61. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages Nat Immunol 6 2005 1123 1132
62. B. Stockinger, and M. Veldhoen Differentiation and function of Th17 T cells Curr Opin Immunol 19 2007 281 286
63. F. Sallusto, C.E. Zielinski, and A. Lanzavecchia Human Th17 subsets Eur J Immunol 42 2012 2215 2220
64. M. Kleinewietfeld, A. Manzel, J. Titze, H. Kvakan, N. Yosef, and R.A. Linker et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells Nature 496 2013 518 522
65. A. Friedman, and H.L. Weiner Induction of anergy or active suppression following oral tolerance is determined by antigen dosage Proc Natl Acad Sci USA 91 1994 6688 6692
66. H.L. Weiner, A.P. da Cunha, F. Quintana, and H. Wu Oral tolerance Immunol Rev 241 2011 241 259
67. D.C. Fitzgerald, G.-X. Zhang, S. Yu, M.L. Cullimore, Z. Zhao, and A. Rostami Intravenous tolerance effectively overcomes enhanced pro-inflammatory responses and experimental autoimmune encephalomyelitis severity in the absence of IL-12 receptor signaling J Neuroimmunol 247 2012 32 37
68. R.S. Liblau, R. Tisch, K. Shokat, X. Yang, N. Dumont, and C.C. Goodnow et al. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis Proc Natl Acad Sci USA 93 1996 3031 3036
69. T.A. Ferguson, J. Choi, and D.R. Green Armed response: How dying cells influence T-cell functions Immunol Rev 241 2011 77 88
70. S. Kontos, I.C. Kourtis, K.Y. Dane, and J.A. Hubbell Engineering antigens for in situ erythrocyte binding induces T-cell deletion Proc Natl Acad Sci USA 21 2012 21 24
71. M. Cremel, N. Guérin, F. Horand, A. Banz, and Y. Godfrin Red blood cells as innovative antigen carrier to induce specific immune tolerance Int J Pharm 443 2013 39 49
72. D.R. Getts, A.J. Martin, D.P. McCarthy, R.L. Terry, Z.N. Hunter, and W.T. Yap et al. Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis Nat Biotechnol 30 2012 1217 1224
73. - T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype Blood 110 2007 2983 2990
74. + regulatory T cells in the human immune system Nat Rev Immunol 10 2010 490 500
75. + regulatory T cells: More of the same or a division of labor? Immunity 30 2009 626 635
76. A. De Groot, L. Moise, J. McMurry, E. Wambre, L. Van Overtvelt, and P. Moingeon et al. Activation of natural regulatory T cells by IgG Fc-derived peptide" Tregitopes" Blood 112 2008 3303
77. S. Tsai, A. Shameli, J. Yamanouchi, X. Clemente-Casares, J. Wang, and P. Serra et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells Immunity 32 2010 568 580
78. N. Joller, S.S. Weber, A.J. Müller, R. Spörri, P. Selchow, and P. Sander et al. Antibodies protect against intracellular bacteria by Fc receptor-mediated lysosomal targeting Proc Natl Acad Sci USA 107 2010 20441 20446
79. A. Casadevall Antibody-mediated protection against intracellular pathogens Trends Microbiol 6 1998 102 107
80. Y. Zhang, M. Meyer-Hermann, L.A. George, M.T. Figge, M. Khan, and M. Goodall et al. Germinal center B cells govern their own fate via antibody feedback J Exp Med 2013
81. H.J. Hinton, A. Jegerlehner, and M.F. Bachmann Pattern recognition by B cells: The role of antigen repetitiveness versus Toll-like receptors Curr Top Microbiol Immunol 319 2008 1 15
82. J. Denis, N. Majeau, E. Acosta-Ramirez, C. Savard, M.-C. Bedard, and S. Simard et al. Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: Evidence for the critical function of multimerization Virology 363 2007 59 68
83. V. Wahl-Jensen, S.K. Kurz, P.R. Hazelton, H.-J. Schnittler, U. Ströher, and D.R. Burton et al. Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages J Virol 79 2005 2413 2419
84. J.S. Rudra, T. Sun, K.C. Bird, M.D. Daniels, J.Z. Gasiorowski, and A.S. Chong et al. Modulating adaptive immune responses to peptide self-assemblies ACS Nano 6 2012 1557 1564
85. J.S. Rudra, Y.F. Tian, J.P. Jung, and J.H. Collier A self-assembling peptide acting as an immune adjuvant Proc Natl Acad Sci USA 107 2010 622 627
86. S.A. Kaba, C. Brando, Q. Guo, C. Mittelholzer, S. Raman, and D. Tropel et al. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria J Immunol 183 2009 7268 7277
87. N. Wahome, T. Pfeiffer, I. Ambiel, Y. Yang, O.T. Keppler, and V. Bosch et al. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine Chem Biol Drug Des 80 2012 349 357
88. U. Schroeder, A. Graff, S. Buchmeier, P. Rigler, U. Silvan, and D. Tropel et al. Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants J Mol Biol 386 2009 1368 1381
89. K.A. Hogquist, S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. Carbone T cell receptor antagonist peptides induce positive selection Cell 76 1994 17 27
90. J.M. Robertson, P.E. Jensen, and B.D. Evavold DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope J Immunol 164 2000 4706 4712
91. B.M. Roy, D.V. Zhukov, and J.A. Maynard Flanking residues are central to DO11.10 T cell hybridoma stimulation by ovalbumin 323-339 PLoS One 7 2012 e47585
92. J.E. Babensee, and A. Paranjpe Differential levels of dendritic cell maturation on different biomaterials used in combination products J Biomed Mater Res A 74A 2005 503 510
93. M. Yoshida, and J.E. Babensee Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation J Biomed Mater Res A 79 2006 393 408
94. S. Hirosue, I.C. Kourtis, A.J. van der Vlies, J.A. Hubbell, and M.A. Swartz Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides cross-presentation and T cell activation Vaccine 2010
95. C.C. Czerkinsky, L.-Å. Nilsson, H. Nygren, Ö. Ouchterlony, and A. Tarkowski A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells J Immunol Methods 65 1983 109 121
96. K.A. Pape, J.J. Taylor, R.W. Maul, P.J. Gearhart, and M.K. Jenkins Different B cell populations mediate early and late memory during an endogenous immune response Science 331 2011 1203 1207
97. P.C. Wilson, and S.F. Andrews Tools to therapeutically harness the human antibody response Nat Rev Immunol 12 2012 709 719
98. J.C. Love, J.L. Ronan, G.M. Grotenbreg, A.G. van der Veen, and H.L. Ploegh A microengraving method for rapid selection of single cells producing antigen-specific antibodies Nat Biotechnol 24 2006 703 707
99. N. Varadarajan, D.S. Kwon, K.M. Law, A.O. Ogunniyi, J.M. Richter, and B.D. Walker et al. Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving Proc Natl Acad Sci USA 109 2012 3885 3890
100. A. Bershteyn, M.C. Hanson, M.P. Crespo, J.J. Moon, A.V. Li, and H. Suh et al. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine J Control Release 157 2012 354 365
101. E.W. Newell, N. Sigal, N. Nair, B.A. Kidd, H.B. Greenberg, and M.M. Davis Combinatorial tetramer staining and mass cytometry analysis facilitate T-cell epitope mapping and characterization Nat Biotechnol 31 2013 623 629
102. J.D. Altman, P.A.H. Moss, P.J.R. Goulder, D.H. Barouch, M.G. McHeyzer-Williams, and J.I. Bell et al. Phenotypic analysis of antigen-specific T lymphocytes Science 274 1996 94 96
103. P. Batard, D.A. Peterson, E. Devêvre, P. Guillaume, J.-C. Cerottini, and D. Rimoldi et al. Dextramers: New generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells J Immunol Methods 310 2006 136 148
104. S.G. Reed, S. Bertholet, R.N. Coler, and M. Friede New horizons in adjuvants for vaccine development Trends Immunol 30 2009 23 32
105. S.T. Reddy, X. Ge, A.E. Miklos, R.A. Hughes, S.H. Kang, and K.H. Hoi et al. Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells Nat Biotechnol 28 2010 965 969
106. B.J. DeKosky, G.C. Ippolito, R.P. Deschner, J.J. Lavinder, Y. Wine, and B.M. Rawlings et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire Nat Biotechnol 31 2013 166 169
107. Y. Wine, D.R. Boutz, J.J. Lavinder, A.E. Miklos, R.A. Hughes, and K.H. Hoi et al. Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response Proc Natl Acad Sci USA 2013
108. P.A. Guerette, S. Hoon, Y. Seow, M. Raida, A. Masic, and F.T. Wong et al. Accelerating the design of biomimetic materials by integrating RNA-seq with proteomics and materials science Nat Biotechnol 31 2013 908 915